Corporate Executive

The Corporate Executive Committee is responsible for managing Bachem worldwide and for implementing policies and strategies as defined by the Board of Directors.

Thomas Meier

Chief Executive Officer (CEO) & Chief Operations Officer (COO)

Thomas Meier joined Bachem AG in 1993 as Team Head, Active Pharmaceutical Ingredients. From 2001 to 2004, he headed up peptide manufacturing at Peninsula Laboratories, Inc. in San Carlos, California. Upon his return to Switzerland, he was in charge of solid-phase peptide manufacturing for Bachem AG in Bubendorf. He assumed overall responsibility for production at the Bubendorf site in 2013, and was appointed COO Europe in August 2017, with responsibility for all production sites in Switzerland, Germany, and the UK. He was appointed COO of the Bachem Group and member of the Corporate Executive Committee in 2019. Since January 1, 2020 Thomas Meier is CEO of the Bachem Group and Chairman of the Corporate Executive Committee. As of September 15, 2023, he also serves as COO in addition to his current role as CEO.
After an apprenticeship as chemical laboratory technician at the ETH in Zurich, Thomas Meier obtained a degree in chemistry from the ZHAW School of Engineering. He obtained in parallel a degree as Industrial Engineer STA (Swiss Technical Association) and completed the Advanced Management Programme at INSEAD Business School, Fontainebleau/Paris.

Alain Schaffter

Chief Financial Officer (CFO)

Alain Schaffter joined Bachem in 2021 as CFO.

He started his career as an auditor at PricewaterhouseCoopers. In 2010, he moved into the pharmaceutical industry and became Head Group Finance of the listed Acino Group before joining Polyphor, a Basel-based biotech company, as CFO in 2016.

In early 2018, he started to work as a consultant for several companies in the Life Science Industry, supporting them in specific projects like Reporting, IFRS conversion or IPO preparation before he became Head Special Finance Projects at Solvias AG in August 2018. There he ran and coordinated the due diligence and deal related activities for the sale of Solvias Group to two Healthcare Investors, including process optimization in the areas of Accounting, Tax and Reporting. After completion of the transaction in June 2020, Alain Schaffter assumed, in addition to his existing role, the role as Head Finance M&A but also as CFO on an ad interim basis.

He served also as a Member of Group Executive Committees and held various mandates as Chairman of the Board of Trustees and as a member of the Board of Directors, of the Management Board and of the Audit Committee at subsidiaries worldwide.

Alain Schaffter holds a degree as a Swiss certified public accountant as well as a Federal certificate of higher vocational education and training for fiduciaries.

Günther Loidl

Chief Technology Officer (CTO)

Guenther Loidl joined Bachem in 2000. He held several functions in Research and Development (R&D) and Active Pharmaceutical Ingredient Manufacturing and became Vice President R&D in 2012. Since 2015, he is CTO of the Bachem Group and a member of the Corporate Executive Committee.

He studied chemistry in Regensburg (Germany) and Leeds (UK) and obtained his doctorate under the supervision of Prof. Dr. Luis Moroder at the Max Planck Institute of Biochemistry in Martinsried (Germany).

He drives building the oligonucleotide business segment and is leading the Bachem innovation initiative.

Torsten Wöhr

Chief Commercial Officer (CCO)

Torsten Wöhr joined Bachem in 2017 as Sales Director for the generic API business and has led Bachem’s oligonucleotide program since 2019.

Previously he held commercial leadership roles in various pharmaceutical manufacturing and life sciences companies in the United States and Europe.

He studied biochemistry & molecular biology at the Swiss Federal Institute of Technology (ETH) Zurich and holds a doctorate in bioorganic chemistry from the University of Lausanne/EPFL and a postgraduate degree in Industrial Engineering and Management, ETH Zurich.


Board of Directors

The Board of Directors are responsible for defining Bachem’s corporate strategy and are elected by the company shareholders.

Click here >>

Leadership Team

Our passionate and dedicated employees, along with our unique corporate culture are the foundation of our success.

Click here >>